RRM2 short interfering ribonucleic acid (RNA) delivery effectively decreased the proliferation of RA fibroblast-like synoviocytes (RA-FLS) and inhibited the secretion of tumor necrosis factor (TNF)-α and interleukin (IL)-6 [13]. This evidence concerns the gene RRM2 and rheumatoid arthritis.